12 Health Care Stocks Moving In Wednesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's after-market session, several healthcare stocks experienced significant movements. Talphera (TLPH) saw a 10.5% increase, while Virpax Pharmaceuticals (VRPX) dropped by 13%. Other notable gainers include Windtree Therapeutics (WINT), Passage Bio (PASG), Bullfrog AI Hldgs (BFRG), Biora Therapeutics (BIOR), and Coeptis Therapeutics (COEP). On the losing side, Adagene (ADAG), Perspective Therapeutics (CATX), INVO Bioscience (INVO), Compass Therapeutics (CMPX), and Petros Pharma (PTPI) saw declines ranging from 7.57% to 11.26%.
January 17, 2024 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Adagene's shares fell by 11.26% to $3.55, with a market cap of $155.6 million.
Adagene's significant after-market drop could reflect investor worries, possibly leading to further short-term declines.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
Perspective Therapeutics' stock decreased by 10.58% to $0.39, with a market cap of $109.4 million.
The drop in Perspective Therapeutics' stock price may lead to bearish sentiment, potentially causing further short-term losses.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
Compass Therapeutics' shares fell by 9.34% to $1.36, with a market cap of $173.3 million.
The decline in Compass Therapeutics' stock price could be indicative of a negative market outlook, potentially leading to further short-term depreciation.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 70
NEGATIVE IMPACT
INVO Bioscience's shares decreased by 9.49% to $1.05, with a market cap of $2.6 million.
INVO Bioscience's after-market decline could signal short-term negative sentiment among investors, possibly leading to further price drops.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 70
NEGATIVE IMPACT
Petros Pharma's stock fell by 7.57% to $1.1, with a market cap of $2.4 million.
Petros Pharma's stock price decline suggests potential short-term selling pressure, which may continue in the near future.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 70
NEGATIVE IMPACT
Virpax Pharmaceuticals' shares fell by 13% to $0.26, with a market cap of $3.0 million.
The sharp decline in Virpax Pharmaceuticals' stock price indicates negative market reaction, potentially leading to further short-term downside.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Bullfrog AI Hldgs' stock increased by 5.8% to $3.37, with a market cap of $20.5 million.
Bullfrog AI Hldgs' after-market rise could be a sign of growing investor interest in AI healthcare, possibly leading to short-term price appreciation.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 70
POSITIVE IMPACT
Biora Therapeutics' stock went up by 5.5% to $1.15, with a market cap of $31.2 million.
The rise in Biora Therapeutics' stock suggests investor optimism, which may lead to further short-term price increases.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 70
POSITIVE IMPACT
Coeptis Therapeutics' shares increased by 5.05% to $0.57, with a market cap of $19.3 million.
Coeptis Therapeutics' stock price gain could indicate a positive trend, potentially leading to short-term upward movement.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 70
POSITIVE IMPACT
Passage Bio's stock rose by 7.02% to $0.98, with a market cap of $53.9 million.
The increase in Passage Bio's stock price may reflect a positive investor outlook, potentially leading to further short-term gains.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Talphera's stock rose by 10.5% to $0.85, with a market cap of $14.4 million.
The significant after-market rise in Talphera's stock price suggests positive investor sentiment, which could lead to a short-term continuation of this upward trend.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Windtree Therapeutics' shares increased by 9.01% to $0.53, with a market cap of $2.7 million.
Windtree Therapeutics' after-market gain could attract investor attention, potentially leading to a short-term uptrend.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80